India's Strategic Plan Against HIV/AIDS

HIV/AIDS Status and Response in India: Key Notes

1. Current Statistics:

   • India has made significant progress in tackling HIV/AIDS over four decades:
     • New infections reduced by nearly 50% since 2010.
     • AIDS-related deaths decreased by over 80%.
     • Viral suppression among individuals on treatment exceeds 97%.
   • HIV prevalence stands at 0.20% nationally; however, states like Assam, Arunachal Pradesh, Tripura, and Punjab show rising incidence primarily due to injecting drug use, where HIV prevalence is 40 times the national average.

2. NACP Overview:

   • The National AIDS and STD Control Programme (NACP) has evolved, with NACP Phase-VI set for 2026-31.
   • Aims to adapt to emerging trends in the HIV epidemic, emphasizing the need for a strategic overhaul.

3. Constitutional and Legislative Framework:

   • HIV and AIDS (Prevention and Control) Act, 2017: Provides a rights-based framework to protect individuals with HIV/AIDS and reduce stigma.
   • Aligns with United Nations Sustainable Development Goal (SDG) 3.3, targeting the end of AIDS as a public health threat by 2030.

4. Strategic Shifts in NACP VI:

   • Evolving Vulnerabilities: Move from categorizing at-risk populations to addressing broader social determinants that create vulnerability.
     • Implementation of universal prevention technologies, including Artificial Intelligence for self-risk assessments and tracking.
   • Treatment Advancement: Focus on "detect early, treat effectively, retain for life."
     • Integration with Ayushman Bharat Health Account (ABHA) for better service linkage and retention.
   • Elimination of Vertical Transmission: Collaboration with Reproductive, Maternal, Newborn, Child, and Adolescent Health (RMNCH+A) to eliminate mother-to-child transmission of HIV and Syphilis by 2030.
   • Stigma Reduction Initiatives: Acknowledgment of stigma as a barrier to diagnosis and treatment; efforts to create a stigma-free environment for service uptake.

5. Demographic Insights:

   • Approximately 2.25 crore adolescents enter the 15-25 age group annually, representing a vulnerable demographic influenced by access to digital platforms.
   • Shift in new infections suggests a need for broader outreach beyond traditional key populations.

6. Public Health and Economic Implications:

   • India's early interventions in HIV prevention and treatment have led to significant public health improvement and potential economic benefits, contributing to a healthier demographic dividend.
   • Ongoing commitment to robust public health systems is vital for sustaining and enhancing these gains.

7. Scientific and Technological Contributions:

   • India’s biotechnology and pharmaceutical sectors are expected to play a crucial role in developing and scaling up treatment options, diagnostics, and vaccines.
   • Emphasis on technological integration in service delivery and data tracking for better health outcomes.

8. Final Notes:

   • NACP-VI is seen as the most ambitious HIV strategy yet, integrating biomedicine with societal interventions to overcome barriers.
   • Acknowledges that achieving the end of AIDS involves collective efforts across scientific, community, and policy domains, emphasizing the interconnectedness of health, technology, and social structures.

These notes encapsulate the critical information relevant to India’s ongoing battle against HIV/AIDS, focusing on strategic initiatives, legal frameworks, demographic considerations, and the significance of reducing stigma as part of a comprehensive public health approach.